Belmont Capital’s Johnson & Johnson JNJ Stock Holding History

Belmont Capital’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$182K	Hold	1,190	–	–	0.03%	125
2025 Q1	$197K	Hold	1,190	–	–	0.04%	121
2024 Q4	$172K	Sell	1,190 -791	-40%	-$123K	0.03%	83
2024 Q3	$321K	Sell	1,981 -7,679	-79%	-$1.22M	0.05%	94
2024 Q2	$1.41M	Hold	9,660	–	–	0.26%	34
2024 Q1	$1.53M	Hold	9,660	–	–	0.42%	26
2023 Q4	$1.51M	Buy	9,660 +4,954	+105%	+$760K	0.65%	22
2023 Q3	$733K	Buy	4,706 +2,899	+160%	+$478K	0.4%	30
2023 Q2	$299K	Sell	1,807 -6	-0.3%	-$968	0.17%	42
2023 Q1	$281K	Hold	1,813	–	–	0.23%	28
2022 Q4	$320K	Hold	1,813	–	–	0.34%	27
2022 Q3	$296K	Sell	1,813 -15,724	-90%	-$2.66M	0.35%	23
2022 Q2	$3.11M	Hold	17,537	–	–	3.77%	6
2022 Q1	$3.11M	Hold	17,537	–	–	3.1%	5
2021 Q4	$3M	Hold	17,537	–	–	2.35%	6
2021 Q3	$2.83M	Buy	17,537 +17,437	+17,437%	+$2.97M	2.3%	7
2021 Q2	$16K	Hold	100	–	–	0.02%	45
2021 Q1	$16K	Hold	100	–	–	0.02%	43
2020 Q4	$16K	Hold	100	–	–	0.01%	45
2020 Q3	$15K	Hold	100	–	–	0.01%	38
2020 Q2	$14K	Hold	100	–	–	0.01%	40
2020 Q1	$13K	Hold	100	–	–	0.01%	35
2019 Q4	$15K	Buy	+100	New	+$13.6K	0.01%	35

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Belmont Capital's JNJ Position: Q2 2025 in Review

Belmont Capital held its Johnson & Johnson (JNJ) position steady in Q2 2025 at 1,190 shares worth $182K. The position accounts for 0.03% of the portfolio, ranked #125.

Belmont Capital first reported a position in JNJ in Q4 2019 and has held it in 23 quarters since. The position peaked at $3.11M in Q2 2022. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

Belmont Capital held 1,190 shares of Johnson & Johnson worth $182K as of Q2 2025.
Belmont Capital left its Johnson & Johnson share count unchanged in Q2 2025.
Johnson & Johnson made up 0.03% of Belmont Capital's portfolio in Q2 2025, its #125 holding.
Belmont Capital first reported a position in Johnson & Johnson in Q4 2019 and has held it in 23 quarters since.
Belmont Capital's Johnson & Johnson position peaked at $3.11M in Q2 2022.
4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Belmont Capital's 13F filing for Q2 2025, filed 12 Aug 2025.